Bill119th CongressFiled Oct 10, 2025Health
H.Res. 803
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it does
A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.
What just happenedOct 10, 2025
Referred to the House Committee on Energy and Commerce.
Who’s behind it
Rep. Rose, John W. [R-TN-6](R-TN)Sponsor
11 cosponsors11 R
11cosponsors1committees3actions
- Introduced in HouseOct 10, 2025
- Oct 10, 2025IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
- Oct 10, 2025IntroReferralH11100
Submitted in House
- Oct 10, 2025IntroReferral1025
Submitted in House